Abstract: A pharmaceutical composition containing 24,25-dihydroxycholecalciferol is provided. The active ingredient used in the present invention is an intrinsic and safe substance, and so does not exhibit hypercalcemia which is the side effect induced by conventional antirachitic agents, and is effective for the treatment of rickets, particularly vitamin D resistant rickets.
Type:
Grant
Filed:
November 8, 1994
Date of Patent:
April 16, 1996
Assignees:
Kureha Chemical Industry Company, Ltd., Yoshiki Seino